Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Maninder Ahluwalia"'
Autor:
Lee Butcher, Maninder Ahluwalia, Tiit Örd, Jessica Johnston, Roger H. Morris, Endre Kiss-Toth, Tõnis Örd, Jorge D. Erusalimsky
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract Megakaryocytopoiesis is a complex differentiation process driven by the hormone thrombopoietin by which haematopoietic progenitor cells give rise to megakaryocytes, the giant bone marrow cells that in turn break down to form blood platelets.
Externí odkaz:
https://doaj.org/article/5476fb0e1b1f4ccab77aedb1a89886b2
Autor:
Maninder Ahluwalia
Publikováno v:
Advances in Genetics ISBN: 9780128237854
The prevalence of non-communicable diseases has been on an upward trajectory for some time and this puts an enormous burden on the healthcare expenditure. Lifestyle modifications including dietary interventions hold an immense promise to manage and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::323d6cf108390e12f1c8d486ae364f20
https://doi.org/10.1016/bs.adgen.2021.08.005
https://doi.org/10.1016/bs.adgen.2021.08.005
Autor:
Raya Hamdan Al-Nasseri, Keith Morris, Nurudeen Hassan, Ahmed Yasine Ali, Maninder Ahluwalia, Cathryn Withycombe, Alex Tonks
Publikováno v:
Cytokine. 108:37-42
Vicenin-2, a C-glycoside flavone that is present in many plant sources, exerts potent anti-inflammatory effects in a number of cell and animal models of inflammation. Ten-eleven translocation (TET)-2 has recently gained considerable attention due to
Autor:
Maninder Ahluwalia
Publikováno v:
New Scientist. 247:23
Henrietta Lacks's cells were used for research without her consent. We still have much to learn from her story, says Maninder Ahluwalia
Autor:
Maninder Ahluwalia, Lee Butcher, Hannah Donovan, Clare L Killick-Cole, Jorge D. Erusalimsky, Paul M. Jones
Publikováno v:
Journal of Thrombosis and Haemostasis. 13:1103-1112
Anagrelide is a cytoreductive agent used to lower platelet counts in essential thrombocythemia. Although the drug has been known to selectively inhibit megakaryopoiesis for many years, the molecular mechanism accounting for this activity is still unc
Autor:
Endre Kiss-Toth, Jessica Johnston, Maninder Ahluwalia, Tõnis Örd, Jorge D. Erusalimsky, Roger H. Morris, Lee Butcher, Tiit Örd
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Scientific Reports
Scientific Reports
Megakaryocytopoiesis is a complex differentiation process driven by the hormone thrombopoietin by which haematopoietic progenitor cells give rise to megakaryocytes, the giant bone marrow cells that in turn break down to form blood platelets. The Trib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac2ca842ad65e5bcb5db0c3d5d0a0a4a
https://eprints.whiterose.ac.uk/118376/7/s41598-017-07096-w.pdf
https://eprints.whiterose.ac.uk/118376/7/s41598-017-07096-w.pdf
Autor:
Amanda Jayne Tonks, K. P. Jones, Roger H. K. Morris, Maninder Ahluwalia, Simon K. Jackson, Alex Tonks, A. W. Thomas
Publikováno v:
Biochemical and Biophysical Research Communications. 370:174-178
The major phospholipid in pulmonary surfactant dipalmitoyl phosphatidylcholine (DPPC) has been shown to modulate inflammatory responses. Using human monocytes, this study demonstrates that DPPC significantly increased PGE(2) (P
Publikováno v:
Lipids in Health and Disease, Vol 10, Iss 1, p 229 (2011)
Lipids in Health and Disease
Lipids in Health and Disease
Background In obesity, phenotypic switches occur in macrophage populations such that the predominantly M2-polarised anti-inflammatory state seen in lean individuals changes to a predominantly M1-polarised pro-inflammatory state in those who are obese
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 8(10)
Summary. Background: Anagrelide is a selective inhibitor of megakaryocytopoiesis used to treat thrombocytosis in patients with chronic myeloproliferative disorders. The effectiveness of anagrelide in lowering platelet counts is firmly established, bu
Publikováno v:
Functional Foods in Health and Disease, Vol 5, Iss 12, Pp 417-426 (2015)
Background : Macrophages are key cellular mediators in diabetes-related inflammation. Molecular cues such as cytokines found in the tissue microenvironment regulates the polarization of macrophages into an M1 (pro-inflammatory) or M2 (immunoregulator